Clinical Rheumatology

, Volume 16, Issue 3, pp 317–318 | Cite as

Psoriatic arthritis and minocycline induced autoantibodies

  • D. N. Leitch
  • D. I. Haslock
Case Report


A case of psoriatic arthritis where diagnosis was originally complicated by the presence of minocycline - induced auto-antibodies and hepatic dysfunction. The range of auto-antibodies associated with minocycline includes ds DNA and SCL 70.

Key words

Minocycline Arthritis Autoantibodies 


  1. 1.
    McKendry RJR. Is rheumatoid arthritis caused by an infection? Lancet 1995; 345: 1319–20.Google Scholar
  2. 2.
    Kloppenburg M, Breedveld FC, Terwiel J, Mallee C, Dijkmans BAC. Minocycline in active rheumatoid arthritis. A double blind, placebo-controlled trial. Arthritis Rheum 1994; 37: 629–36.Google Scholar
  3. 3.
    Tilley BC, Alarcon GS, Heyse SP et al. Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. Ann Intern Med 1995; 122: 81–8.Google Scholar
  4. 4.
    Byrne PAC, Williams BD, Pritchard MH. Minocycline-related lupus. Br J Rheum 1994; 33: 674–6.Google Scholar
  5. 5.
    Gordon PM, White MI, Herriot R, Martin JC, Reid DM. Minocycline-associated lupus erythematosus. Br J Dermatol 1995; 132: 120–121.Google Scholar
  6. 6.
    Matasuura T, Shimizu Y, Fujimoto H, Miyazaki T, Kano S. Minocycline-related lupus. Lancet 1992; 340: 1553.Google Scholar
  7. 7.
    Bulgen DY. Minocycline-related lupus. Br J Rheum 1995; 34: 398.Google Scholar
  8. 8.
    Gough A, Chapman S, Wagstaff K, Emery P, Elias E. Minocycline induced autoimmune hepatitis and systemic lupus erythematosus-like syndrome. BMJ 1996; 312: 169–72.Google Scholar

Copyright information

© Clinical Rheumatology 1997

Authors and Affiliations

  • D. N. Leitch
    • 1
  • D. I. Haslock
    • 1
  1. 1.Department of RheumatologySouth Cleveland HospitalMiddlesbrough

Personalised recommendations